ARTL – artelo biosciences, inc. (US:NASDAQ)
Stock Stats
News
Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access; Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Candidate
Artelo Biosciences Announces Publication of New Peer-Reviewed Study Demonstrating Intraperitoneal Administration of a Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor Significantly Reduces Stress-Induced Anxiety and Depression Behaviors in Preclinical
Artelo Biosciences (NASDAQ:ARTL) had its "hold" rating reaffirmed by analysts at Maxim Group.
Artelo Biosciences (NASDAQ:ARTL) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Artelo Biosciences Provides Business Update and Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
Form D ARTELO BIOSCIENCES, INC.
Form 8-K ARTELO BIOSCIENCES, INC. For: Jan 30
Form 8-K ARTELO BIOSCIENCES, INC. For: Feb 02
Form 4 ARTELO BIOSCIENCES, INC. For: Jan 30 Filed by: MATSUI CONNIE
Form 4 ARTELO BIOSCIENCES, INC. For: Jan 30 Filed by: Blayney Douglas
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.